secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K/A
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001493152-25-022013
Event type: earnings
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Elite Pharmaceuticals Corrects Conference Call Date for Q2 Fiscal 2026 Results
------------------------------------------------------------------------------

- Q2 FY2026 financial results (ended Sept 30, 2025) to be released on Friday, November 14, 2025.
- Conference call scheduled for Monday, November 17, 2025 at 11:30 AM EST to discuss results and provide update.
- Form 8-K/A amends prior filing solely to correct the conference call date in Item 7.01.
- Dial-in: 1-800-346-7359 (domestic) or 1-973-528-0008 (international); conference ID 98840.
- Stockholder questions due by 5:00 PM EST on Nov 13 (general) and 7:00 PM EST on Nov 14 (financial).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315225022013/0001493152-25-022013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315225022013/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-022013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer